Psychosocial care for people with diabetes: A position statement of the American Diabetes Association. Diabetes care 2016;39:2126-2140

Deborah Young-Hyman; Mary De Groot; Felicia Hill-Briggs; Jeffrey Gonzalez; Korey Hood; Mark Peyrot

doi:10.2337/dci16-0051

Psychosocial care for people with diabetes: A position statement of the American Diabetes Association. Diabetes care 2016;39:2126-2140

Deborah Young-Hyman, Mary De Groot, Felicia Hill-Briggs, Jeffrey Gonzalez, Korey Hood, Mark Peyrot

School of Medicine

Research output: Contribution to journal › Letter › peer-review

4 Scopus citations

Original language	English (US)
Pages (from-to)	e131-e132
Journal	Diabetes care
Volume	40
Issue number	9
DOIs	https://doi.org/10.2337/dci16-0051
State	Published - Sep 1 2017

ASJC Scopus subject areas

Internal Medicine
Endocrinology, Diabetes and Metabolism
Advanced and Specialized Nursing

Access to Document

10.2337/dci16-0051

Cite this

@article{df05fa69641c43e985ceaaa34eff2c5f,

title = "Psychosocial care for people with diabetes: A position statement of the American Diabetes Association. Diabetes care 2016;39:2126-2140",

author = "Deborah Young-Hyman and {De Groot}, Mary and Felicia Hill-Briggs and Jeffrey Gonzalez and Korey Hood and Mark Peyrot",

note = "Funding Information: Acknowledgments. The content of this re sponse reflects the views of the ADA psychosocial guidelines Position Statement authors. The National Institutes of Health supports the science that informs clinical guidelines. Funding. Funding for the participation of M.d.G. in the preparation of this article came in part from the National Institute of Diabetes and Digestive and Kidney Diseases (R18-DK-092765). J.G. is supported by grants from the National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health (R01-DK-104845, R18-DK-098742, and P30-DK-111022). Duality of Interest. F.H.-B. is a member of the ADA Board of Directors. K.H. has served as a consultant to Bigfoot Biomedical and Johnson & Johnson Diabetes Institute and received research support from Dexcom. M.P. has received research grants from Bristol-Myers Squibb, Genentech, and Novo Nordisk; has received consulting fees from AstraZeneca, Calibra, Genentech, Eli Lilly, and Novo Nordisk; has received speaking honoraria from Novo Nordisk; and has participated in advisory panels for GlaxoSmithKline, Eli Lilly, and Novo Nordisk. No other potential conflicts of interest relevant to this article were reported.",

year = "2017",

month = sep,

day = "1",

doi = "10.2337/dci16-0051",

language = "English (US)",

volume = "40",

pages = "e131--e132",

journal = "Diabetes care",

issn = "0149-5992",

publisher = "American Diabetes Association Inc.",

number = "9",

}

TY - JOUR

T1 - Psychosocial care for people with diabetes

T2 - A position statement of the American Diabetes Association. Diabetes care 2016;39:2126-2140

AU - Young-Hyman, Deborah

AU - De Groot, Mary

AU - Hill-Briggs, Felicia

AU - Gonzalez, Jeffrey

AU - Hood, Korey

AU - Peyrot, Mark

N1 - Funding Information: Acknowledgments. The content of this re sponse reflects the views of the ADA psychosocial guidelines Position Statement authors. The National Institutes of Health supports the science that informs clinical guidelines. Funding. Funding for the participation of M.d.G. in the preparation of this article came in part from the National Institute of Diabetes and Digestive and Kidney Diseases (R18-DK-092765). J.G. is supported by grants from the National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health (R01-DK-104845, R18-DK-098742, and P30-DK-111022). Duality of Interest. F.H.-B. is a member of the ADA Board of Directors. K.H. has served as a consultant to Bigfoot Biomedical and Johnson & Johnson Diabetes Institute and received research support from Dexcom. M.P. has received research grants from Bristol-Myers Squibb, Genentech, and Novo Nordisk; has received consulting fees from AstraZeneca, Calibra, Genentech, Eli Lilly, and Novo Nordisk; has received speaking honoraria from Novo Nordisk; and has participated in advisory panels for GlaxoSmithKline, Eli Lilly, and Novo Nordisk. No other potential conflicts of interest relevant to this article were reported.

PY - 2017/9/1

Y1 - 2017/9/1

UR - http://www.scopus.com/inward/record.url?scp=85028034898&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85028034898&partnerID=8YFLogxK

U2 - 10.2337/dci16-0051

DO - 10.2337/dci16-0051

M3 - Letter

C2 - 28830965

AN - SCOPUS:85028034898

SN - 0149-5992

VL - 40

SP - e131-e132

JO - Diabetes care

JF - Diabetes care

IS - 9

ER -

Psychosocial care for people with diabetes: A position statement of the American Diabetes Association. Diabetes care 2016;39:2126-2140

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this